Stockreport

Aradigm Announces Detailed Third Party Evaluation Results for Apulmiq (FDA)/Linhaliq (EMA)

ARADIGM CORP COMMON STOCK  (ARDM) 
US:NASDAQ Investor Relations: investor.aradigm.com
PDF HAYWARD, Calif.--(BUSINESS WIRE)-- Aradigm Corporation (OTCQB: ARDM) ("Aradigm" or the "Company") today announced specific, detailed results of an independ [Read more]